Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested ā papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: āSafety and efficacy of pralsetinib in RET fusionāpositive non-small-cell lung cancer including as first-line therapy: update from the ARROW trialā.
Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more